Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
about
Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamasesMoxalactam therapy for a wide spectrum of bacterial infections in adults.Clinical evaluation of moxalactam.Is it reasonable to use cephalosporins in respiratory and upper tract renal infections in hospitalized patients?Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.Pharmacology, Safety, and efficacy of cefamandole in childhood infections.Bacterial pneumonia in the elderly: a reappraisal of conventional therapy, with a note on cefamandole.
P2860
Q24597685-447D9ACC-F4B3-4A8C-BEC2-AB5D1B719D8BQ35669539-C2920221-8BA0-42B1-84A9-8DB9FE7FF657Q35670939-47C2A642-CA82-4FD6-8443-4428636AA390Q35876841-43464AE9-BC30-4F8D-82B3-965709443ED4Q37329147-457AD264-A756-4C4A-BAA7-CB159667091EQ39855394-36B57968-85EF-4C37-A4DD-D99C45FD2AA4Q41688697-8AFE425A-CEA8-43E1-9158-BEB457A8B571
P2860
Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Cefamandole nafate therapy of ...... sue infections in 74 patients.
@en
type
label
Cefamandole nafate therapy of ...... sue infections in 74 patients.
@en
prefLabel
Cefamandole nafate therapy of ...... sue infections in 74 patients.
@en
P2093
P1476
Cefamandole nafate therapy of ...... sue infections in 74 patients.
@en
P2093
Gardner WG
Perkins RL
P304
P356
10.1093/INFDIS/137.SUPPLEMENT.S110
P407
P478
P577
1978-05-01T00:00:00Z